Natural Alternatives International Inc (NAII) Financial Statements
Industry: Medicinal Chemicals & Botanical Products
In fiscal 2026, Natural Alternatives International reported revenue of $142.5M, up 9.7% from $129.9M the year before. Net income was -$20.7M (a -14.5% net margin), or -$3.43 per diluted share. Gross margin was 6.3% and operating margin was -13.2%. Operating activities generated -$8.9M of cash, leaving -$12.6M of free cash flow. At fiscal year end, Natural Alternatives International held $126.4M in total assets against $76.5M in total liabilities, including $7.4M of cash and equivalents.
Open the full interactive Natural Alternatives International financials → Quarterly statements, key ratios, valuation history and price charts.
Natural Alternatives International Key Stats
| Share Price | $1.15 |
|---|---|
| Market Cap | $6.9M |
| Revenue YoY Growth | +9.8% |
| 52-Week Range | $1.14 – $4.83 |
| Shares Outstanding | 6.0 million (basic, 2026 Q4) |
Natural Alternatives International Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $178.5M | $171.0M | $154.0M | $113.8M | $129.9M | $142.5M |
| Cost of Goods Sold | $148.1M | $140.5M | $135.9M | $106.9M | $120.6M | $133.5M |
| Gross Profit | $30.4M | $30.5M | $18.2M | $6.9M | $9.3M | $9.0M |
| Operating Income | $13.7M | $13.7M | $4.7M | -$8.5M | -$8.7M | -$18.8M |
| Pre-Tax Income | $12.1M | $13.7M | $3.6M | -$9.5M | -$10.7M | -$20.3M |
| Income Tax | $1.4M | $2.9M | $1.0M | -$2.2M | $2.8M | $430,000 |
| Net Income | $10.8M | $10.7M | $2.5M | -$7.2M | -$13.6M | -$20.7M |
| Diluted EPS | $1.69 | $1.74 | $0.43 | -$1.23 | -$2.28 | -$3.43 |
Natural Alternatives International Quarterly Results
| 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | |
|---|---|---|---|---|
| Revenue | $37.7M | $34.8M | $35.5M | $34.5M |
| Net Income | -$291,000 | -$2.6M | -$4.3M | -$13.5M |
| Diluted EPS | -$0.05 | -$0.42 | -$0.72 | -$2.25 |
Natural Alternatives International Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $32.1M | $21.8M | $13.6M | $12.0M | $12.3M | $7.4M |
| Current Assets | $80.3M | $76.7M | $57.0M | $61.6M | $59.3M | $65.4M |
| Total Assets | $120.3M | $146.0M | $134.2M | $162.3M | $151.9M | $126.4M |
| Current Liabilities | $22.1M | $23.3M | $15.9M | $23.5M | $28.8M | $37.7M |
| Total Long-Term Debt | — | $9.8M | $9.5M | $9.2M | $8.9M | $10.9M |
| Total Liabilities | $40.2M | $57.5M | $45.4M | $79.7M | $83.5M | $76.5M |
| Shareholders' Equity | $80.1M | $88.5M | $88.8M | $82.6M | $68.4M | $50.0M |
Natural Alternatives International Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $20.8M | $11.9M | $7.0M | -$1.5M | $5.9M | -$8.9M |
| Cash From Investing | -$5.0M | -$26.5M | -$13.5M | -$3.0M | -$3.6M | -$3.7M |
| Cash From Financing | -$14.1M | $4.3M | -$1.8M | $2.9M | -$2.0M | $7.8M |
| Free Cash Flow | $15.7M | -$14.6M | -$6.5M | -$4.5M | $2.3M | -$12.6M |
Figures from Natural Alternatives International's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Natural Alternatives International financials page for every line item.
Natural Alternatives International Company Profile
| Ticker | NAII |
|---|---|
| Exchange | Nasdaq |
| Industry | Medicinal Chemicals & Botanical Products |
| Headquarters | Carlsbad, California |
| Incorporated in | Delaware |
| Fiscal Year End | June 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0000787253 |
Frequently Asked Questions
What was Natural Alternatives International's revenue in fiscal 2026?
Natural Alternatives International (NAII) reported revenue of $142.5M for fiscal 2026.
What is Natural Alternatives International's annual revenue history?
Natural Alternatives International's annual revenue by fiscal year: 2021: $178.5M; 2022: $171.0M; 2023: $154.0M; 2024: $113.8M; 2025: $129.9M; 2026: $142.5M.
What was Natural Alternatives International's net income in fiscal 2026?
Natural Alternatives International reported net income of -$20.7M for fiscal 2026.
What was Natural Alternatives International's earnings per share (EPS) in fiscal 2026?
Natural Alternatives International's diluted EPS was -$3.43 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Natural Alternatives International generate in fiscal 2026?
Natural Alternatives International generated -$12.6M of free cash flow in fiscal 2026.
What was Natural Alternatives International's revenue last quarter?
In its most recent reported quarter (2026 Q4), Natural Alternatives International reported revenue of $34.5M.
How much debt does Natural Alternatives International have?
Natural Alternatives International reported $10.9M of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Natural Alternatives International are outstanding?
Natural Alternatives International reported a weighted average of 6.0 million basic shares outstanding in 2026 Q4.
What is Natural Alternatives International's market cap?
Based on its latest closing price, Natural Alternatives International (NAII) has a market capitalization of about $6.9M.
When does Natural Alternatives International's fiscal year end?
Natural Alternatives International's fiscal year end, as registered with the SEC, is June 30.
Where is Natural Alternatives International headquartered?
Natural Alternatives International lists its business address in Carlsbad, California in its SEC filings.
Natural Alternatives International Competitors & Similar Companies
See all 11 Medicinal Chemicals & Botanical Products companies →